[PDF] Top 20 Predictors of response to TNF blockers in patients with polyarticular psoriatic arthritis

... clinical response, EULAR good/ /moderate response, 28-joint Disease Activity Score with three variables including the erythrocyte sedi- mentation rate (DAS28-3V-ESR) remission and Health Assessment ... See full document

... spectrum of infectious conditions is quite variable, depending on the country of registry and the type of TNF-a blocker ...33% of non-tuberculosis opportunistic infections among users ... See full document

... disease with or without joint ...application of vitamin D analogs are widely used in the treatment of psoria- sis ...levels of vitamin D, a crucial factor in the regulation ... See full document

... anti-TNF response previously found in a Dutch cohort (n = 182) [18]. In that study, both rs5744174 and another TLR5 polymorphism (rs2072493) in linkage disequilibrium (genetic distance: ... See full document

... cycles with two infusions every six months. Response to treatment was assessed by DAS28, HAQ/CHAQ, and an overall assessment by the doctor and the ...patient. Of our six patients, four ... See full document

... or polyarticular asym- metrical peripheral joint inflammation or axial ...involvement. In the last few years several crite- ria have been used for the classification of ...diagnosis of PsA is ... See full document

... assessment of response and switching biological therapies in patients with ...ripheral arthritis, axial disease, enthesitis and ...guidance in deciding which ... See full document

... Rheumatoid arthritis (RA) is a chronic, systemic dis- order with unknown etiology, which is characterized by involvement of hand joints and deformation ...disorder with ambiguous borders, ... See full document

... 2% to 5% of the population older than ...manifestations of Paget’s disease are pain and bone deformity, although the majority of patients are ...asymptomatic. Psoriatic ... See full document

... effect of disease duration on treat- ment response and long-term outcomes in patients with PsA are limited, and the role of biologics in the mana - gement of early ... See full document

... associated with rheumatic and non- rheumatic diseases. Few cases of peripheral corneal melting have been reported in patients with ...shown to decrease skin and serum metallopro- ... See full document

... adult patients with moderate to severe active psoriat- ic arthritis (at least three swollen and painful joints) or who have chronic plaque psoriatic skin lesions or inadequate re- ... See full document

... le in a sample of patients with RA, psoriatic arthritis and SA, observed differences between the two agents, the i rst being associated with increases in TC and ... See full document

... tion of DMARD treatment (years), corticosteroid treatment (ever or never), patient’s/parent’s disease global activity VAS, physician’s global disease activity VAS, and extra-articular manifestations (yes or ... See full document

... limitation of our study was that MRI assessment of sacroiliitis was performed only when clinically ...led to an underdiagnosis of axial non-radiographic SpA. Patients with this ... See full document

... MTX in patients with inl ammatory bowel disease, it is note- worthy that less than 9% of patients with this type of impair- ment were using ...use in ... See full document

... use of a large routine database of unselected patients seen in ordinary rheumatology outpatient clinic allowed a unique opportunity of direct comparison between RA, PsA and ax- SpA ... See full document

... type of ovarian cancer; representing 90% of all ovarian ...tried to analyze the presence of Hepatitis B Virus infection in women with epithelial ovarian ...detection of ... See full document

... seen in all cases of AS. Enthesopathy was noted in all cases of AS with heel pain being the most common manifestation followed by plantar fasciitis and ...test with limited chest ... See full document

... study. Patients with known diabetes mellitus (ie., patients with a history of diabetes who were on a dia- betic diet or on treatment with oral hypoglycemic drugs or using ... See full document